Similarly, single treatment with crizotinib in human neuroblastoma xenograft models expressing ALK­-addicted cell lines reduces tumor growth but does not substantially debulk or eradicate tumors (Umapathy et al., 2014). This evidence concerns the gene ALK and neuroblastoma.